Singapore markets open in 24 minutes
Straits Times Index
3,264.53 -35.51 (-1.08%) S&P 500
5,187.67 -0.03 (-0.00%) Dow
39,056.39 +172.13 (+0.44%) Nasdaq
16,302.76 -29.80 (-0.18%) Bitcoin USD
61,340.84 -890.15 (-1.43%) CMC Crypto 200
1,303.94 +9.27 (+0.72%)
CEL-SCI Corporation (CVM)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.6700 |
| Open | 1.8600 |
| Bid | 1.4200 x 4000 |
| Ask | 1.5200 x 1300 |
| Day's range | 1.3600 - 2.3900 |
| 52-week range | 1.0400 - 3.2300 |
| Volume | |
| Avg. volume | 308,318 |
| Market cap | 75.031M |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 28 Aug 1996 |
| 1y target est | N/A |
- Business Wire
CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
VIENNA, Va., May 08, 2024--CEL-SCI receives FDA go-ahead for its confirmatory study of Multikine in the treatment of head & neck cancer.
- Business Wire
CEL-SCI Appoints Mario Gobbo to Its Board of Directors
VIENNA, Va., April 23, 2024--CEL-SCI appoints Mario Gobbo to its Board of Directors.
- Business Wire
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
VIENNA, Va., March 19, 2024--CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology.
© 2024 Yahoo. All rights reserved.